United Therapeutics

ISIN US91307C1027

WKN 923818

Marktkapitalisatie (in EUR)

17,184 m

Land

United States

Sector

Healthcare

Dividendrendement

0.00%

Overzicht

Koers

Beschrijving

United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD.

Toon meer Toon minder

Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States

Grafiek

Financiële kerngegevens

Kerncijfers

Marktkapitalisatie, EUR	17,184 m
WPA, EUR	23.90
KBV	3.0
K/W	17.7
Dividendrendement	0.00%

Income statement (2024)

Omzet, EUR	2,660 m
Netto-inkomen, EUR	1,105 m
Winstmarge	41.53%

What ETF is United Therapeutics in?

There are 26 ETFs which contain United Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of United Therapeutics is the iShares Nasdaq US Biotechnology UCITS ETF USD (Dist).

ETF	Weging	Investeringsfocus	Fondsgrootte (in m EUR)
UBS Core MSCI World UCITS ETF USD acc	0.03%	Equity World	6,074
iShares MSCI World UCITS ETF (Dist)	0.03%	Equity World	7,338
iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist)	0.07%	Equity World Health Care Social/Environmental	516
Xtrackers MSCI World UCITS ETF 1D	0.03%	Equity World	4,534
iShares Edge MSCI USA Quality Factor UCITS ETF USD (Dist)	0.08%	Equity United States Fundamental/Quality	136
JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist)	0.33%	Equity United States Small Cap	183
iShares MSCI USA ESG Enhanced CTB UCITS ETF USD (Dist)	0.01%	Equity United States Social/Environmental	13,128
iShares MSCI North America UCITS ETF	0.03%	Equity North America	1,085
UBS Core MSCI World UCITS ETF USD dis	0.03%	Equity World	1,316
iShares MSCI World Screened UCITS ETF USD (Dist)	0.03%	Equity World Social/Environmental	940
JPMorgan Global Research Enhanced Index Equity (ESG) UCITS ETF USD (dist)	0.03%	Equity World Social/Environmental	1,846
UBS Core MSCI World UCITS ETF hGBP dis	0.03%	Equity World	93
JPMorgan All Country Research Enhanced Index Equity Active UCITS ETF USD (dist)	0.03%	Equity World Social/Environmental	50
UBS Core MSCI USA UCITS ETF USD dis	0.03%	Equity United States	1,164
iShares MSCI ACWI UCITS ETF USD (Acc)	0.03%	Equity World	21,789
Amundi MSCI North America ESG Broad Transition UCITS ETF Dist	0.01%	Equity North America Social/Environmental Climate Change	40
iShares Edge MSCI World Value Factor UCITS ETF USD (Dist)	0.09%	Equity World Value	217
iShares MSCI USA Screened UCITS ETF USD (Dist)	0.04%	Equity United States Social/Environmental	1,304
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing	0.03%	Equity World Social/Environmental	486
UBS Core MSCI World UCITS ETF hEUR acc	0.03%	Equity World	364
UBS Core MSCI USA UCITS ETF EUR Hedged dis	0.03%	Equity United States	263
iShares MSCI World ESG Enhanced CTB UCITS ETF USD (Dist)	0.01%	Equity World Social/Environmental	961
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	1.73%	Equity United States Health Care Biotech	45
Vanguard ESG North America All Cap UCITS ETF (USD) Distributing	0.04%	Equity North America Social/Environmental	24
iShares Edge MSCI USA Value Factor UCITS ETF USD (Dist)	0.19%	Equity United States Value	112
JPMorgan US Research Enhanced Index Equity SRI Paris Aligned UCITS ETF USD (dist)	0.05%	Equity United States Social/Environmental Climate Change	2

Prestaties

Rendementsoverzicht

YTD	-5,94%
1 maand	-8,92%
3 maanden	+10,30%
6 maanden	+60,38%
1 jaar	+13,84%
3 jaar	+66,94%
5 jaar	+191,41%
Since inception	+210,11%
2025	+25,36%
2024	+72,03%
2023	-23,04%
2022	+34,87%

Maandelijks rendement in een heat map

Risico

Risk metrics in this section:

Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.

ETF-rendementen zijn inclusief dividenduitkeringen (indien van toepassing).